These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 6484308)

  • 1. Correlation between covalent attachment of C3 and calcium uptake in antibody-stimulated L cells.
    Shearer WT; Moore EG
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):163-78. PubMed ID: 6484308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immunostimulation. VI. Increased calcium uptake by cells treated with antibody and complement.
    Shearer WT; Atkinson JP; Parker CW
    J Immunol; 1976 Sep; 117(3):973-80. PubMed ID: 956662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody and complement modulation of tumor cell growth in vitro and in vivo.
    Shearer WT; Parker CW
    Fed Proc; 1978 Aug; 37(10):2385-9. PubMed ID: 354972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum.
    Puentes SM; Dwyer DM; Bates PA; Joiner KA
    J Immunol; 1989 Dec; 143(11):3743-9. PubMed ID: 2584716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the complement C3 protein in the control of the specific immune response].
    Villiers CL; Villiers MB; Marche PN
    Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial protein HbhA binds human complement component C3.
    Mueller-Ortiz SL; Wanger AR; Norris SJ
    Infect Immun; 2001 Dec; 69(12):7501-11. PubMed ID: 11705926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN; Nilsson B
    J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immunostimulation. VIII. Increased incorporation of phosphate and turnover of phosphatidylinositol in cells treated with antibody.
    Shearer WT; Crouch JA
    J Immunol; 1977 Sep; 119(3):911-7. PubMed ID: 894029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG-protein A complexes modulate thymidine incorporation into DNA of antibody and complement-stimulated cells.
    Shearer WT; Green CG; Patel P; Langone JJ
    J Immunol; 1984 May; 132(5):2279-84. PubMed ID: 6715880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of L cell growth by antibody-stimulated incorporation of radioactive nucleosides.
    Shearer WT; Philpott GW; Parker CW
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):303-9. PubMed ID: 1171516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.
    Schwendinger MG; Spruth M; Schoch J; Dierich MP; Prodinger WM
    J Immunol; 1997 Jun; 158(11):5455-63. PubMed ID: 9164968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
    Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
    J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD21 and synthesis of its ligands by HeLa cells after growth in serum-free medium.
    Michael EJ; McClellan M; Huebner H; Hostetter MK
    J Lab Clin Med; 1995 Jan; 125(1):102-12. PubMed ID: 7822938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin binds to C3 and enhances complement activation.
    Mishra S; Moulik S; Murphy LJ
    Mol Immunol; 2007 Mar; 44(8):1897-902. PubMed ID: 17070910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.